Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2015, Pages

  Zhang, Lun ^a   Li, Jiahui ^a   Zong, Liang ^a   Chen, Xin ^a   Chen, Ke ^a   Jiang, Zhengdong ^a   Nan, Ligang ^a   Li, Xuqi ^a   Li, Wei ^a   Shan, Tao ^a   Ma, Qingyong ^a   Ma, Zhenhua ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CELL DEATH; CELLS; CYTOLOGY;

CANCER CELLS; CANCER PROGRESSION; ELEVATED LEVEL; PANCREATIC CANCERS; REACTIVE OXYGEN SPECIES; ROS GENERATIONS; SCAVENGING ABILITY; TUMOR MICROENVIRONMENT;

DISEASES;

REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

CANCER CELL; CANCER THERAPY; DRUG TARGETING; HUMAN; OXIDATIVE STRESS; PANCREAS CANCER; REVIEW; SIGNAL TRANSDUCTION; APOPTOSIS; CARCINOGENESIS; CHEMISTRY; DISEASE COURSE; DNA DAMAGE; METABOLISM; PANCREATIC NEOPLASMS; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CARCINOGENESIS; DISEASE PROGRESSION; DNA DAMAGE; HUMANS; OXIDATIVE STRESS; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84961300812     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1616781     Document Type: Review

References (101)

1. S. T. Lau, Z. X. Lin, and P. S. Leung, "Role of reactive oxygen species in brucein D-mediated p38-mitogen-Activated protein kinase and nuclear factor-B signalling pathways in human pancreatic adenocarcinoma cells, " British Journal of Cancer, vol. 102, no. 3, pp. 583-593, 2010.
2. N. McCarthy, "Tumorigenesis: oncogene detox programme, " Nature Reviews Cancer, vol. 11, no. 9, pp. 622-623, 2011.
3. W. Li, Q. Ma, J. Li et al. , "Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide, " Oncology Reports, vol. 25, no. 5, pp. 1279-1287, 2011.
4. J. P. Fruehauf and F. L. Meyskens Jr. , "Reactive oxygen species: A breath of life or death?" Clinical Cancer Research, vol. 13, no. 3, pp. 789-794, 2007.
5. C. R. Reczek and N. S. Chandel, "ROS-dependent signal transduction, " Current Opinion in Cell Biology, vol. 33, pp. 8-13, 2015.
6. C. Gorrini, I. S. Harris, andT. W. Mak, "Modulationof oxidative stress as an anticancer strategy, " Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931-947, 2013.
7. D. Trachootham, J. Alexandre, and P. Huang, "Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?" Nature Reviews Drug Discovery, vol. 8, no. 7, pp. 579-591, 2009.
8. C. L. Quinlan, J. R. Treberg, I. V. Perevoshchikova, A. L. Orr, and M. D. Brand, "Native rates of superoxide production from multiple sites in isolated mitochondria measured using endogenous reporters, " Free Radical Biology and Medicine, vol. 53, no. 9, pp. 1807-1817, 2012.
9. R. P. Brandes, N. Weissmann, and K. Schröder, "Nox family NADPH oxidases: molecular mechanisms of activation, " Free Radical Biology and Medicine, vol. 76, pp. 208-226, 2014.
10. M. Schieber and N. S. Chandel, "ROS function in redox signaling and oxidative stress, " Current Biology, vol. 24, no. 10, pp. R453-R462, 2014.
11. I. Fridovich, "Superoxide anion radical (O 2), superoxide dismutases, and related matters, " The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18515-18517, 1997.
12. J. Boonstra and J. A. Post, "Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells, " Gene, vol. 337, pp. 1-13, 2004.
13. A. P. Wojtovich and T. H. Foster, "Optogenetic control of ROS production, " Redox Biology, vol. 2, no. 1, pp. 368-376, 2014.
14. M. A. Lemmon and J. Schlessinger, "Cell signaling by receptor tyrosine kinases, " Cell, vol. 141, no. 7, pp. 1117-1134, 2010.
15. I. Afanasev, "Reactive oxygen species signaling in cancer: comparison with aging, " Aging andDisease, vol. 2, no. 3, pp. 219-230, 2011.
16. M. Donadelli, I. Dando, T. Zaniboni et al. , "Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism, " Cell Death & Disease, vol. 2, no. 4, article e152, 2011.
17. B. Vurusaner, G. Poli, and H. Basaga, "Tumor suppressor genes and ROS: complex networks of interactions, " Free Radical Biology and Medicine, vol. 52, no. 1, pp. 7-18, 2012.
18. K. Bishayee, A. R. Khuda-Bukhsh, and S. O. Huh, "PLGAloaded gold-nanoparticles precipitated with quercetin downregulateHDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells, " Molecules and Cells, vol. 38, no. 6, pp. 518-527, 2015.
19. C. Jose, N. Bellance, and R. Rossignol, "Choosing between glycolysis and oxidative phosphorylation: A tumors dilemma?" Biochimica et BiophysicaActa-Bioenergetics, vol. 1807, no. 6, pp. 552-561, 2011.
20. S. S. Sabharwal and P. T. Schumacker, "Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles heel?" Nature Reviews Cancer, vol. 14, no. 11, pp. 709-721, 2014.
21. S. W. Kang, S. Lee, and E. K. Lee, "ROS and energy metabolism in cancer cells: Alliance for fast growth, " Archives of Pharmacal Research, vol. 38, no. 3, pp. 338-345, 2015.
22. E. C. Vaquero, M. Edderkaoui, S. J. Pandol, I. Gukovsky, and A. S. Gukovskaya, "Reactive oxygen species produced by NAD (P) H oxidase inhibit apoptosis in pancreatic cancer cells, " Journal of Biological Chemistry, vol. 279, no. 33, pp. 34643-34654, 2004.
23. R. K. Gupta, A. K. Patel, N. Shah et al. , "Oxidative stress and antioxidants in disease and cancer: A review, " Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4405-4409, 2014.
24. N. Couto, N. Malys, S. J. Gaskell, and J. Barber, "Partition and turnover of glutathione reductase from saccharomyces cerevisiae: A proteomic approach, " Journal of Proteome Research, vol. 12, no. 6, pp. 2885-2894, 2013.
25. K. M. Halprin and A. Ohkawara, "The measurement of glutathione in human epidermis using glutathione reductase, " Journal of Investigative Dermatology, vol. 48, no. 2, pp. 149-152, 1967.
26. J. E. Klaunig and L. M. Kamendulis, "The role of oxidative stress in carcinogenesis, " Annual Review of Pharmacology and Toxicology, vol. 44, pp. 239-267, 2004.
27. Q. Kong, J. A. Beel, and K. O. Lillehei, "A threshold concept for cancer therapy, " Medical Hypotheses, vol. 55, no. 1, pp. 29-35, 2000.
28. B. Ramanathan, K.-Y. Jan, C.-H. Chen, T.-C. Hour, H.-J. Yu, and Y.-S. Pu, "Resistance topaclitaxel is proportional to cellular total antioxidant capacity, " Cancer Research, vol. 65, no. 18, pp. 8455-8460, 2005.
29. R. F. Hwang, T. Moore, T. Arumugam et al. , "Cancer-Associated stromal fibroblasts promote pancreatic tumor progression, " Cancer Research, vol. 68, no. 3, pp. 918-926, 2008.
30. M. V. Apte, S. Park, P. A. Phillips et al. , "Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells, " Pancreas, vol. 29, no. 3, pp. 179-187, 2004.
31. J. Lei, X. Huo, W. Duan et al. , "Mangostin inhibits hypoxiadriven ROS-induced PSC activation and pancreatic cancer cell invasion, " Cancer Letters, vol. 347, no. 1, pp. 129-138, 2014.
32. C. Fiorini, M. Cordani, G. Gotte, D. Picone, and M. Donadelli, "Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROSdependent manner, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1853, no. 3, pp. 549-560, 2015.
33. R. Kong, G. Jia, Z.-X. Cheng et al. , "Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5, " PLoS ONE, vol. 7, no. 5, Article ID e37222, 2012.
34. S. Suzuki, M. Okada, K. Shibuya et al. , "JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells, " Oncotarget, vol. 6, no. 1, pp. 458-470, 2015.
35. X. Wang, A. K. Mandal, H. Saito et al. , "Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitisassociated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/-catenin signaling pathway, " Toxicology and Applied Pharmacology, vol. 262, no. 1, pp. 11-21, 2012.
36. L. Liu, H. R. Rezvani, J. H. Back et al. , "Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation, " PLoS ONE, vol. 9, no. 5, Article ID e97245, 2014.
37. D. Ziech, I. Anestopoulos, R. Hanafi et al. , "Pleiotrophic effects of natural products in ROS-induced carcinogenesis: The role of plant-derived natural products in oral cancer chemoprevention, " Cancer Letters, vol. 327, no. 1-2, pp. 16-25, 2012.
38. S. Yang, X. Wang, G. Contino et al. , "Pancreatic cancers require autophagy for tumor growth, " Genes&Development, vol. 25, no. 7, pp. 717-729, 2011.
39. S. Yang and A. C. Kimmelman, "A critical role for autophagy in pancreatic cancer, " Autophagy, vol. 7, no. 8, pp. 912-913, 2011.
40. C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim, and M. Perucho, "Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes, " Cell, vol. 53, no. 4, pp. 549-554, 1988.
41. V. T. H. B. M. Smit, A. J. M. Boot, A. M. M. Smits, G. J. Fleuren, C. J. Cornelisse, and J. L. Bos, "KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas, " Nucleic Acids Research, vol. 16, no. 16, pp. 7773-7782, 1988.
42. M. Ogrunc, R. Di Micco, M. Liontos et al. , "Oncogeneinduced reactive oxygen species fuel hyperproliferation and DNAdamage response activation, " CellDeath&Differentiation, vol. 21, no. 6, pp. 998-1012, 2014.
43. M. Edderkaoui, P. Hong, E. C. Vaquero et al. , "Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 6, pp. G1137-G1147, 2005.
44. M. G. Binker, A. A. Binker-Cosen, D. Richards, B. Oliver, and L. I. Cosen-Binker, "EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2, " Biochemical and Biophysical Research Communications, vol. 379, no. 2, pp. 445-450, 2009.
45. M. G. Binker, A. A. Binker-Cosen, H. Y. Gaisano, R. H. de Cosen, and L. I. Cosen-Binker, "TGF-1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-B/IL-6/MMP-2, " Biochemical and Biophysical Research Communications, vol. 405, no. 1, pp. 140-145, 2011.
46. H. Sawai, H. Funahashi, Y. Okada et al. , "Interleukin-1 enhances IL-8 secretion through p38mitogen-Activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells, " Medical Science Monitor, vol. 11, no. 10, pp. BR343-BR350, 2005.
47. W. Li, L. Cao, L. Han, Q. Xu, andQ. Ma, "Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-B axis, " International Journal of Oncology, vol. 46, no. 6, pp. 2613-2620, 2015.
48. R. Hiraga, M. Kato, S. Miyagawa, and T. Kamata, "Nox4-derived ROS signaling contributes to TGF-induced epithelialmesenchymal transition in pancreatic cancer cells, " Anticancer Research, vol. 33, no. 10, pp. 4431-4438, 2013.
49. Y. Xi, Y. Wei, B. Sennino et al. , "Identification of pY654-catenin as a critical co-factor in hypoxia-inducible factor-1 signaling and tumor responses to hypoxia, " Oncogene, vol. 32, no. 42, pp. 5048-5057, 2013.
50. Y. Shimojo, M. Akimoto, T. Hisanaga et al. , "Attenuation of reactive oxygen species by antioxidants suppresses hypoxiainduced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells, " Clinical&ExperimentalMetastasis, vol. 30, no. 2, pp. 143-154, 2013.
51. J. Liu, Q.-W. Ben, W.-Y. Yao et al. , "BMP2 Induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK, " Frontiers in Bioscience, vol. 17, no. 7, pp. 2541-2549, 2011.
52. S. Cannito, E. Novo, A. Compagnone et al. , "Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells, " Carcinogenesis, vol. 29, no. 12, pp. 2267-2278, 2008.
53. R. Mezencev, L. Wang, W. Xu et al. , "Molecular analysis of the inhibitory effect of N-Acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells, " Anti-Cancer Drugs, vol. 24, no. 5, pp. 504-518, 2013.
54. Y. Wu, S. Antony, S. M. Hewitt et al. , "Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and humanmalignancies characterized with a novel monoclonal antibody, " International Journal of Oncology, vol. 42, no. 4, pp. 1229-1238, 2013.
55. H.-B. Cheng, Y. Bo, W.-X. Shen et al. , "Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS, " Naunyn-Schmiedebergs Archives of Pharmacology, vol. 388, no. 6, pp. 623-634, 2015.
56. J. Gong, A. R. Muñoz, D. Chan, R. Ghosh, and A. P. Kumar, "STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth, " Oncotarget, vol. 5, no. 9, pp. 2529-2541, 2014.
57. T. Sakurai, M. Kudo, N. Fukuta et al. , "Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis, " Pancreatology, vol. 11, no. 2, pp. 7-13, 2011.
58. J. J. Cullen, C. Weydert, M. M. Hinkhouse et al. , "The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma, " Cancer Research, vol. 63, no. 6, pp. 1297-1303, 2003.
59. S. Y. Park, I. Chang, J.-Y. Kimet al. , "Resistanceofmitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase, " Journal of Biological Chemistry, vol. 279, no. 9, pp. 7512-7520, 2004.
60. X. Deng, D. Z. Ewton, and E. Friedman, "Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species, " Cancer Research, vol. 69, no. 8, pp. 3317-3324, 2009.
61. G. M. DeNicola, F. A. Karreth, T. J. Humpton et al. , "Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis, " Nature, vol. 475, no. 7354, pp. 106-109, 2011.
62. M. Kobayashi and M. Yamamoto, "Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species, " Advances in Enzyme Regulation, vol. 46, no. 1, pp. 113-140, 2006.
63. J. Zhou and Y. Du, "Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase, " Molecular Cancer Research, vol. 10, no. 6, pp. 768-777, 2012.
64. D. Z. Ewton, J. Hu, M. Vilenchik et al. , "Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells, " Molecular Cancer Therapeutics, vol. 10, no. 11, pp. 2104-2114, 2011.
65. S.Ten Raa, H. M. U. van Grevenstein, M.Ten Kate et al. , "The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum, " Cell Adhesion & Migration, vol. 1, no. 2, pp. 77-83, 2007.
66. M. Ten Kate, A. G. J. Aalbers, W. Sluiter et al. , "Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium, " Anticancer Research, vol. 27, no. 1, pp. 17-22, 2007.
67. M.Ten Kate, J. B. C. van der Wal, W. Sluiter et al. , "The role of superoxide anions in the development of distant tumour recurrence, " British Journal of Cancer, vol. 95, no. 11, pp. 1497-1503, 2006.
68. D. Pathania, M. Sechi, M. Palomba et al. , "Design and discovery of novel quinazolinedione-based redoxmodulators as therapies for pancreatic cancer, " Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 1, pp. 332-343, 2014.
69. X. Li, F. Zhu, J. Jiang et al. , "Synergistic antitumor activity of withaferinAcombinedwith oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells, " Cancer Letters, vol. 357, no. 1, pp. 219-230, 2015.
70. S. Ghavami, M. Hashemi, S. R. Ande et al. , "Apoptosis and cancer: mutations within caspase genes, " Journal of Medical Genetics, vol. 46, no. 8, pp. 497-510, 2009.
71. W. Zhao, D. Li, Z. Liu, X. Zheng, J. Wang, and E. Wang, "Spiclomazine induces apoptosis associated with the suppression of cell viability, migration and invasion in pancreatic carcinoma cells, " PLoS ONE, vol. 8, no. 6, Article ID e66362, 2013.
72. Z. Liu, D. Li, W. Zhao, X. Zheng, J. Wang, andE. Wang, "Apotent lead induces apoptosis in pancreatic cancer cells, " PLoS ONE, vol. 7, no. 6, Article ID e37841, 2012.
73. G. G. Mackenzie, L. Huang, N. Alston et al. , "Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice, " PLoS ONE, vol. 8, no. 5, Article ID e61532, 2013.
74. I. Dando, C. Fiorini, E. D. Pozza et al. , "UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1833, no. 3, pp. 672-679, 2013.
75. H. Q. Ju, T. Gocho, M. Aguilar et al. , "Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation, " Molecular CancerTherapeutics, vol. 14, no. 3, pp. 788-798, 2015.
76. S.-H. Chen, D.-L. Li, F. Yang, Z. Wu, Y.-Y. Zhao, and Y. Jiang, "Gemcitabine-induced pancreatic cancer cell death is associated with MST1/Cyclophilin D mitochondrial complexation, " Biochimie, vol. 103, pp. 71-79, 2014.
77. L. Li, G. G. L. Yue, J. X. Pu et al. , "Eriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiolcontaining antioxidant systems and downstream signalling pathways, " Current Molecular Medicine, vol. 14, no. 5, pp. 673-689, 2014.
78. S. Noori, Z. M. Hassan, and V. Farsam, "Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line, " Chinese Journal of IntegrativeMedicine, vol. 20, no. 8, pp. 618-623, 2014.
79. S. A. Curley, F. Palalon, X. Lu, andN. V. Koshkina, "Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells, " Cancer, vol. 120, no. 21, pp. 3418-3425, 2014.
80. K. Larocque, P. Ovadje, S. Djurdjevic, M. Mehdi, J. Green, and S. Pandey, "Novel analogue of colchicine induces selective prodeath autophagy and necrosis in human cancer cells, " PLoS ONE, vol. 9, no. 1, Article ID e87064, 2014.
81. Y. Xia, Q. Lei, Y. Zhu et al. , "SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo, " Cancer Letters, vol. 355, no. 2, pp. 297-309, 2014.
82. Y. Song, T. Baba, Y.-Y. Li et al. , "Gemcitabine-induced CXCL8 expression counteracts its actions by inducing tumor neovascularization, " Biochemical and Biophysical Research Communications, vol. 458, no. 2, pp. 341-346, 2015.
83. M. S. Wason, J. Colon, S. Das et al. , "Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 4, pp. 558-569, 2013.
84. J. Wei, M. Liu, H. Liu et al. , "Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells, " Journal of Applied Toxicology, vol. 33, no. 8, pp. 756-765, 2013.
85. D. Deeb, X. Gao, Y. Liu, N. R. S. Varma, A. S. Arbab, and S. C. Gautam, "Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROSdependent, " Molecules, vol. 18, no. 3, pp. 3250-3265, 2013.
86. D. Deeb, X. Gao, Y. B. Liu, and S. C. Gautam, "Inhibition of cell proliferation and induction of apoptosis by CDDOMe in pancreatic cancer cells is ROS-dependent, " Journal of ExperimentalTherapeutics & Oncology, vol. 10, no. 1, pp. 51-64, 2012.
87. B. Wang, X.-B. Wang, L.-Y. Chen, L. Huang, and R.-Z. Dong, "Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis, " Biochemical and Biophysical Research Communications, vol. 437, no. 1, pp. 1-6, 2013.
88. D. Li, Z. Liu, W. Zhao, X. Zheng, J. Wang, and E. Wang, "A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells, " European Journal of Pharmaceutical Sciences, vol. 48, no. 4-5, pp. 658-667, 2013.
89. M. Khan, C. Ding, A. Rasul et al. , "Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells, " International Journal of Biological Sciences, vol. 8, no. 4, pp. 533-547, 2012.
90. Z. Liu, D. Li, L. Yu, and F. Niu, "Gallic acid as a cancerselective agent induces apoptosis in pancreatic cancer cells, " Chemotherapy, vol. 58, no. 3, pp. 185-194, 2012.
91. H.-Q. Duong, J. S. Hwang, H. J. Kim, Y.-S. Seong, and I. Bae, "BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells, " International Journal of Oncology, vol. 41, no. 6, pp. 2227-2236, 2012.
92. M. Z. Hossainl and M. G. Kleve, "Nickel nanowires induced and reactive oxygen species mediated apoptosis in human pancreatic adenocarcinoma cells, " International Journal of Nanomedicine, vol. 6, no. 1, pp. 1475-1485, 2011.
93. M. C. Messner and M. C. Cabot, "Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells, " Cancer Chemotherapy and Pharmacology, vol. 68, no. 2, pp. 477-487, 2011.
94. P. Naumann, F. Fortunato, H. Zentgraf, M. W. Büchler, I. Herr, and J. Werner, "Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer, " International Journal of Oncology, vol. 39, no. 1, pp. 101-109, 2011.
95. J.-H. Du, H.-D. Zhang, Z.-J. Ma, and K.-M. Ji, "Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo, " Cancer Chemotherapy and Pharmacology, vol. 65, no. 5, pp. 895-902, 2010.
96. H. Zhou, L. Huang, Y. Sun, and B. Rigas, "Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling, " Cancer Letters, vol. 273, no. 2, pp. 292-299, 2009.
97. R. P. Sahu, R. Zhang, S. Batra, Y. Shi, and S. K. Srivastava, "Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells, " Carcinogenesis, vol. 30, no. 10, pp. 1744-1753, 2009.
98. W. Wang, M. Adachi, R. Zhang, J. Zhou, and D. Zhu, "A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells, " Pancreas, vol. 38, no. 4, pp. e114-e123, 2009.
99. Y. Shi, R. P. Sahu, and S. K. Srivastava, "Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis, "BMC Cancer, vol. 8, no. 1, article 294, 2008.
100. R. Zhang, I. Humphreys, R. P. Sahu, Y. Shi, and S. K. Srivastava, "In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation andmitochondrial death pathway, " Apoptosis, vol. 13, no. 12, pp. 1465-1478, 2008.
101. W. Sun, W. Wang, J. Kim et al. , "Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment, " in Oxygen Transport to Tissue XXIX, vol. 614 of Advances In ExperimentalMedicine And Biology, pp. 179-186, Springer, New York, NY, USA, 2008.